Figure 2a.
The 5-year progression free survival (months) for all patients trated with cyclophosphamide, doxorubicin, vincristine and prednisolone with rituximab
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.